NextGen Biomed (XTAE:NXGN) Price-to-Operating-Cash-Flow : (As of Jun. 07, 2024)

View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed Price-to-Operating-Cash-Flow?

As of today (2024-06-07), NextGen Biomed's share price is ₪1.018. NextGen Biomed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₪-0.53. Hence, NextGen Biomed's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for NextGen Biomed's Price-to-Operating-Cash-Flow or its related term are showing as below:

XTAE:NXGN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.46
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

NextGen Biomed's Cash Flow from Operations per share for the six months ended in Jun. 2023 was ₪-0.33. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₪-0.53.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.00% per year.

During the past 9 years, NextGen Biomed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 60.50% per year. The lowest was -17.30% per year. And the median was 13.55% per year.

NextGen Biomed Price-to-Operating-Cash-Flow Historical Data

The historical data trend for NextGen Biomed's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextGen Biomed Price-to-Operating-Cash-Flow Chart

NextGen Biomed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

NextGen Biomed Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial													-	-	-	-	-

Competitive Comparison of NextGen Biomed's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, NextGen Biomed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NextGen Biomed's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NextGen Biomed's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NextGen Biomed's Price-to-Operating-Cash-Flow falls into.

NextGen Biomed Price-to-Operating-Cash-Flow Calculation

NextGen Biomed's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.018	/	-0.529
	=

NextGen Biomed's Share Price of today is ₪1.018.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NextGen Biomed's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₪-0.53.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

NextGen Biomed Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NextGen Biomed's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

NextGen Biomed (XTAE:NXGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101

Website

http://www.nextgen-biomed.com

NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.